Martell Christopher

Martell Christopher is listed in filings as Director at Candel Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 26, 2025, including 3 public disclosures. Recent filings connect the profile to Candel Therapeutics, Inc. (CADL). The current snapshot covers public activity from Jun 27, 2024 to Jun 26, 2025. Reported amounts are shown as $81.3K to $520.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.